Additionally, Li et al. used the protein transferrin, which is known to favor cancer cells due to the overexpression of the transferrin receptor on their membranes, to perform targeting of cancer cells that they postulate and can then be used in drug delivery [68]. Here, TFRC is linked to cancer.